Breaking newsCOVID-19
Persistent visual dysfunction following PRES due to COVID-19: Case series and literature review
Persistent visual dysfunction following PRES due to COVID-19: Case series and literature review
Event marks major milestone in EAN’s strategic efforts to shape the future of neurology and strengthen collaboration at both European and national levels.
Latest Posts
-
-
Risk and outcomes of COVID-19 in patients with multiple sclerosis -
Breaking newsCOVID-19Predictive factors of smell recovery in a clinical series of 288 COVID-19 patients with olfactory dysfunction
Predictive factors of smell recovery in a clinical series of 288 COVID-19 patients with olfactory dysfunction -
Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 vaccine
-
Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination
-
Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19
-
Breaking newsCOVID-19
Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation
Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation -
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
-
Breaking newsCOVID-19
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species -
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
-
Breaking newsCOVID-19
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals -
Breaking newsCOVID-19
Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection
Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection -
Breaking newsCOVID-19
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection -
Breaking newsCOVID-19The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis -
Breaking newsCOVID-19
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis